Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Pharming (PHAR) EBT Margin (2020 - 2025)

Historic EBT Margin for Pharming (PHAR) over the last 6 years, with Q3 2025 value amounting to 125.69%.

  • Pharming's EBT Margin rose 1202000.0% to 125.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.04%, marking a year-over-year increase of 138900.0%. This contributed to the annual value of 2.9% for FY2024, which is 7000.0% down from last year.
  • Pharming's EBT Margin amounted to 125.69% in Q3 2025, which was up 1202000.0% from 2.21% recorded in Q2 2025.
  • Over the past 5 years, Pharming's EBT Margin peaked at 484.88% during Q1 2022, and registered a low of 37.16% during Q3 2021.
  • For the 5-year period, Pharming's EBT Margin averaged around 29.88%, with its median value being 0.02% (2021).
  • Per our database at Business Quant, Pharming's EBT Margin plummeted by -542300bps in 2021 and then soared by 4848800bps in 2022.
  • Over the past 5 years, Pharming's EBT Margin (Quarter) stood at 13.73% in 2021, then tumbled by -342bps to 33.15% in 2022, then surged by 80bps to 6.63% in 2023, then plummeted by -40bps to 9.3% in 2024, then surged by 1451bps to 125.69% in 2025.
  • Its EBT Margin was 125.69% in Q3 2025, compared to 2.21% in Q2 2025 and 8.91% in Q1 2025.